These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22459053)

  • 21. Primary central nervous system lymphoma after liver transplantation treated by radiosurgery combined with fractionated radiotherapy.
    Kim MS; Lee JI; Kim WS; Ko YH
    J Clin Neurosci; 2009 Apr; 16(4):583-5. PubMed ID: 19200738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent advances in the treatment of primary central nervous system lymphoma].
    Nakamaki T
    Brain Nerve; 2014 Aug; 66(8):969-79. PubMed ID: 25082318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
    Agarwal PA; Menon S; Smruti BK; Singhal BS
    Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International study on low-grade primary central nervous system lymphoma.
    Jahnke K; Korfel A; O'Neill BP; Blay JY; Abrey LE; Martus P; Poortmans PM; Shenkier TN; Batchelor TT; Neuwelt EA; Raizer JJ; Schiff D; Pels H; Herrlinger U; Stein H; Thiel E
    Ann Neurol; 2006 May; 59(5):755-62. PubMed ID: 16586496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
    Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
    Abrey LE; Batchelor TT; Ferreri AJ; Gospodarowicz M; Pulczynski EJ; Zucca E; Smith JR; Korfel A; Soussain C; DeAngelis LM; Neuwelt EA; O'Neill BP; Thiel E; Shenkier T; Graus F; van den Bent M; Seymour JF; Poortmans P; Armitage JO; Cavalli F;
    J Clin Oncol; 2005 Aug; 23(22):5034-43. PubMed ID: 15955902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
    J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
    J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
    Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
    Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
    Ney DE; Reiner AS; Panageas KS; Brown HS; DeAngelis LM; Abrey LE
    Cancer; 2010 Oct; 116(19):4605-12. PubMed ID: 20572045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
    Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
    Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
    Reni M; Ferreri AJ
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatment approaches in primary central nervous system lymphoma.
    Soussain C; Hoang-Xuan K; Doolittle ND
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):719-28, vii. PubMed ID: 16083832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
    Juergens A; Pels H; Rogowski S; Fliessbach K; Glasmacher A; Engert A; Reiser M; Diehl V; Vogt-Schaden M; Egerer G; Schackert G; Reichmann H; Kroschinsky F; Bode U; Herrlinger U; Linnebank M; Deckert M; Fimmers R; Schmidt-Wolf IG; Schlegel U
    Ann Neurol; 2010 Feb; 67(2):182-9. PubMed ID: 20225195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.
    Kiefer T; Krüger WH; Montemurro M; Schüler F; Hirt C; Pasold R; Niederwieser D; Schwenke M; Dölken G
    Transfusion; 2008 Dec; 48(12):2624-8. PubMed ID: 18801020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.